These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 32442543)
61. Combined effect of organophosphorus hydrolase and oxime on the reactivation rate of diethylphosphoryl-acetylcholinesterase conjugates. Ashani Y; Leader H; Rothschild N; Dosoretz C Biochem Pharmacol; 1998 Jan; 55(2):159-68. PubMed ID: 9448738 [TBL] [Abstract][Full Text] [Related]
62. In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesterase. Jun D; Musilova L; Musilek K; Kuca K Int J Mol Sci; 2011; 12(3):2077-87. PubMed ID: 21673941 [TBL] [Abstract][Full Text] [Related]
63. A Novel, Modified Human Butyrylcholinesterase Catalytically Degrades the Chemical Warfare Nerve Agent, Sarin. McGarry KG; Lalisse RF; Moyer RA; Johnson KM; Tallan AM; Winters TP; Taris JE; McElroy CA; Lemmon EE; Shafaat HS; Fan Y; Deal A; Marguet SC; Harvilchuck JA; Hadad CM; Wood DW Toxicol Sci; 2020 Mar; 174(1):133-146. PubMed ID: 31879758 [TBL] [Abstract][Full Text] [Related]
64. Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review. Lorke DE; Petroianu GA J Appl Toxicol; 2019 Jan; 39(1):101-116. PubMed ID: 30027640 [TBL] [Abstract][Full Text] [Related]
65. Binary combinations of organophosphorus and synthetic pyrethroids are more potent acetylcholinesterase inhibitors than organophosphorus and carbamate mixtures: An in vitro assessment. Arora S; Balotra S; Pandey G; Kumar A Toxicol Lett; 2017 Feb; 268():8-16. PubMed ID: 27988393 [TBL] [Abstract][Full Text] [Related]
66. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Raveh L; Grauer E; Grunwald J; Cohen E; Ashani Y Toxicol Appl Pharmacol; 1997 Jul; 145(1):43-53. PubMed ID: 9221822 [TBL] [Abstract][Full Text] [Related]
67. Progress in the development of enzyme-based nerve agent bioscavengers. Nachon F; Brazzolotto X; Trovaslet M; Masson P Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386 [TBL] [Abstract][Full Text] [Related]
68. Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases. Radić Z; Sit RK; Kovarik Z; Berend S; Garcia E; Zhang L; Amitai G; Green C; Radić B; Fokin VV; Sharpless KB; Taylor P J Biol Chem; 2012 Apr; 287(15):11798-809. PubMed ID: 22343626 [TBL] [Abstract][Full Text] [Related]
69. Neurotoxicity of acute and repeated treatments of tabun, paraoxon, diisopropyl fluorophosphate and isofenphos to the hen. Henderson JD; Higgins RJ; Dacre JC; Wilson BW Toxicology; 1992; 72(2):117-29. PubMed ID: 1566275 [TBL] [Abstract][Full Text] [Related]
70. The tertiary oxime monoisonitrosoacetone penetrates the brain, reactivates inhibited acetylcholinesterase, and reduces mortality and morbidity following lethal sarin intoxication in guinea pigs. Shih TM; Oyler BL; Capacio BR; Koplovitz I Toxicol Appl Pharmacol; 2021 Mar; 415():115443. PubMed ID: 33548273 [TBL] [Abstract][Full Text] [Related]
71. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase. Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134 [TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetics and immunologic consequences of exposing macaques to purified homologous butyrylcholinesterase. Rosenberg Y; Luo C; Ashani Y; Doctor BP; Fischer R; Wolfe G; Saxena A Life Sci; 2002 Nov; 72(2):125-34. PubMed ID: 12417246 [TBL] [Abstract][Full Text] [Related]
73. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate. Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910 [TBL] [Abstract][Full Text] [Related]
74. Amino acid residues at the N- and C-termini are essential for the folding of active human butyrylcholinesterase polypeptide. Naik RS; Pattabiraman N; Patel KA; Doctor BP; Saxena A Chem Biol Interact; 2013 Mar; 203(1):24-9. PubMed ID: 23044488 [TBL] [Abstract][Full Text] [Related]
75. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes. Caranto GR; Waibel KH; Asher JM; Larrison RW; Brecht KM; Schutz MB; Raveh L; Ashani Y; Wolfe AD; Maxwell DM Biochem Pharmacol; 1994 Jan; 47(2):347-57. PubMed ID: 8304979 [TBL] [Abstract][Full Text] [Related]
76. Interaction of pyridinium oximes with acetylcholinesterase and their effect on organophosphate-poisoned mice. Kovarik Z; Calić M; Vrdoljak AL; Radić B J Mol Neurosci; 2006; 30(1-2):113-4. PubMed ID: 17192653 [TBL] [Abstract][Full Text] [Related]
77. The effect of fluoride on the scavenging of organophosphates by human butyrylcholinesterase in buffer solutions and human plasma. Ashani Y; Segev O; Balan A Toxicol Appl Pharmacol; 2004 Jan; 194(1):90-9. PubMed ID: 14728983 [TBL] [Abstract][Full Text] [Related]